JP2019501861A5 - - Google Patents

Download PDF

Info

Publication number
JP2019501861A5
JP2019501861A5 JP2017566080A JP2017566080A JP2019501861A5 JP 2019501861 A5 JP2019501861 A5 JP 2019501861A5 JP 2017566080 A JP2017566080 A JP 2017566080A JP 2017566080 A JP2017566080 A JP 2017566080A JP 2019501861 A5 JP2019501861 A5 JP 2019501861A5
Authority
JP
Japan
Prior art keywords
drug
aqueous solvent
organic compound
concentration
hydrophobic organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017566080A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019501861A (ja
JP6836825B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/066999 external-priority patent/WO2017009480A1/en
Publication of JP2019501861A publication Critical patent/JP2019501861A/ja
Publication of JP2019501861A5 publication Critical patent/JP2019501861A5/ja
Application granted granted Critical
Publication of JP6836825B2 publication Critical patent/JP6836825B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017566080A 2015-07-16 2016-07-15 水不溶性またはわずかに水溶性の薬剤の水可溶性を改善するための方法 Active JP6836825B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201514801578A 2015-07-16 2015-07-16
US14/801,578 2015-07-16
PCT/EP2016/066999 WO2017009480A1 (en) 2015-07-16 2016-07-15 Method for improving aqueous solubility of water-insoluble or slightly water-soluble drugs

Publications (3)

Publication Number Publication Date
JP2019501861A JP2019501861A (ja) 2019-01-24
JP2019501861A5 true JP2019501861A5 (https=) 2019-07-11
JP6836825B2 JP6836825B2 (ja) 2021-03-03

Family

ID=56418519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017566080A Active JP6836825B2 (ja) 2015-07-16 2016-07-15 水不溶性またはわずかに水溶性の薬剤の水可溶性を改善するための方法

Country Status (29)

Country Link
EP (1) EP3324933B1 (https=)
JP (1) JP6836825B2 (https=)
KR (1) KR102615005B1 (https=)
CN (1) CN107847440B (https=)
AU (1) AU2016293125B2 (https=)
CA (1) CA2992376C (https=)
CL (1) CL2018000032A1 (https=)
CO (1) CO2018001460A2 (https=)
CY (1) CY1124322T1 (https=)
DK (1) DK3324933T3 (https=)
EA (1) EA036233B1 (https=)
ES (1) ES2844581T3 (https=)
HR (1) HRP20210333T1 (https=)
HU (1) HUE053116T2 (https=)
IL (1) IL256882B (https=)
LT (1) LT3324933T (https=)
MA (1) MA42472B1 (https=)
MX (1) MX379341B (https=)
MY (1) MY196065A (https=)
NZ (1) NZ738592A (https=)
PH (1) PH12018500042A1 (https=)
PL (1) PL3324933T3 (https=)
PT (1) PT3324933T (https=)
RS (1) RS61561B1 (https=)
SA (1) SA518390688B1 (https=)
SI (1) SI3324933T1 (https=)
UA (1) UA123312C2 (https=)
WO (1) WO2017009480A1 (https=)
ZA (1) ZA201708594B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108143713A (zh) * 2018-01-04 2018-06-12 南方医科大学南方医院 一种增加羟喜树碱溶解度的方法
US12377046B1 (en) 2019-04-24 2025-08-05 Wellomics LLC Delivery system matrices
CN110074385B (zh) * 2019-05-21 2022-05-31 绥化市蓝源生物工程有限公司 一种生物碱溶解纳他霉素的生物溶剂及其应用
KR20220022829A (ko) * 2020-08-19 2022-02-28 주식회사 모든바이오 글리시리진 및 수용성 약물을 포함하는 나노 입자, 이를 포함하는 약제학적 조성물 및 이들의 제조 방법
CN114588118B (zh) * 2022-01-25 2023-05-23 武汉爱民制药股份有限公司 一种注射用七叶皂苷钠复方制剂
KR102922176B1 (ko) * 2022-07-08 2026-02-04 한국생산기술연구원 소수성 약물 전달을 위한 금-히알루론산 나노입자의 제조방법
EP4431082A1 (en) * 2023-03-13 2024-09-18 Marinomed Biotech AG Aqueous composition comprising budesonide
EP4516289A1 (en) 2023-08-30 2025-03-05 SPH Sine Pharmaceutical Laboratories Co., Ltd Antiviral nasal spray comprising favipiravir
CN117562911B (zh) * 2023-12-07 2024-06-04 海南医学院 化合物tigloside在制备治疗和/或预防骨关节炎药物中的用途
WO2025133675A1 (en) * 2023-12-20 2025-06-26 Melikoglu, Ahmet Method for producing nasal formulation comprising aescin and rutin
EP4696300A1 (en) 2024-08-14 2026-02-18 Marinomed Biotech AG Aqueous composition comprising fluticasone
KR102907892B1 (ko) * 2025-01-09 2026-01-12 주식회사 한바이오 가용성을 높인 피레스로이드계의 보건용 스프레이 살충제 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1119957A (en) 1979-12-04 1982-03-16 Martin Whitefield Steroid compositions
US4782047A (en) 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US4868170A (en) 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
JPH1025255A (ja) * 1996-07-11 1998-01-27 Taisho Pharmaceut Co Ltd 溶解性の改善された難溶性薬剤
FR2799369B1 (fr) 1999-10-08 2001-12-21 Oreal Association d'escine et de sulfate de dextran et son utilisation
US7125564B2 (en) 2001-02-16 2006-10-24 Lavipharm Laboratories, Inc. Water soluble and palatable complexes
JP4000283B2 (ja) * 2002-08-07 2007-10-31 丸善製薬株式会社 甘草油性抽出物の可溶化組成物、並びに飲料、液状調味料、化粧品及び医薬部外品
US7897587B2 (en) 2004-09-03 2011-03-01 Nycomed Us Inc. Topical dermatological formulations and use thereof
JP5128801B2 (ja) * 2006-10-16 2013-01-23 フロイント産業株式会社 高水分散性粉末とその製造方法
JP6265624B2 (ja) * 2012-05-11 2018-01-24 ロート製薬株式会社 ルリコナゾール含有外用医薬組成物
US9907846B2 (en) * 2013-04-01 2018-03-06 Mx Adjuvac Ab Nanoparticles, composed of sterol and saponin from Quillaja saponaria Molina for use in pharmaceutical compositions
CN103271891B (zh) * 2013-04-28 2016-01-06 福建南方制药股份有限公司 人参皂苷纳米胶束及其制备方法、应用和药物组合物
CN103520081B (zh) * 2013-09-27 2015-10-28 无限极（中国）有限公司 一种调节皮肤免疫力、延缓皮肤老化的外用护肤品

Similar Documents

Publication Publication Date Title
JP2019501861A5 (https=)
US8349882B2 (en) Pharmaceutical composition for external use
KR102681877B1 (ko) 수-혼화성, 약학적으로 허용가능한 용매의 수성 혼합물 내 로플루밀라스트의 약학 조성물
DK2613793T3 (en) NOSE SPRAY
HRP20210333T1 (hr) Postupak za poboljšanje topivosti lijekova netopivih ili blago topivih u vodi
KR102718482B1 (ko) 디쿠아포솔을 포함하는 점안 조성물
EP3677265B1 (en) Composition for preventing or treating sleep disorders
US20130171237A1 (en) Aripiprazole compositions and methods for its transdermal delivery
CN105395528A (zh) 依匹哌唑口腔速溶膜
KR100878198B1 (ko) 미녹시딜을 포함하는 겔 조성물
HRP20200444T1 (hr) U vodi visoko topive soli kratko djelujućeg fenilalkilamina blokatora kalcijevih kanala i njihova uporaba
TWI712429B (zh) 水性醫藥組成物
CN103211755A (zh) 无菌稳定的阿奇霉素滴眼液的生产方法
US20090142321A1 (en) Opthalmic composition
CN105101966A (zh) 一种含埃克替尼的皮肤外用药物组合物及其应用
KR102540472B1 (ko) (r)-n-[1-(3,5-다이플루오로-4-메테인설폰일아미노-페닐)-에틸]-3-(2-프로필-6-트라이플루오로메틸-피리딘-3-일)-아크릴아마이드를 함유하는 약학 조성물
ES2629103T3 (es) Formulación en polvo de valganciclovir
TH1801000045A (th) วิธีการสำหรับการปรับปรุงความสามารถในการละลายในน้ำได้ของยาที่ละลายน้ำได้เล็กน้อยหรือที่ละลายในน้ำไม่ได้
JP3533551B2 (ja) 水性点鼻剤
JP5627235B2 (ja) 眼科用組成物
CN105878173B (zh) 一种七叶皂苷钠搽剂
US20090088421A1 (en) Intranasal Anti-Convulsive Compositions And Methods
RU2022106937A (ru) Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза
HK40017700A (en) Pharmaceutical composition containing (r)-n-[1-(3,5-difluoro-4-methansulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethyl-pyridin-3-yl)-acrylamide
US20200405701A1 (en) Pharmaceutical composition containing (r)-n-[1-(3,5-difluoro-4-methanesulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethylpyridin-3-yl)-acrylamide and method for inhibiting crystal formation thereof